[Dyskinesia after treatment with droperidol for preventing postoperative nausea and vomiting]. / Dyskinesi efter droperidolbehandling for postoperativ kvalme og opkastning.

This case presents a young woman with extrapyramidal reactions after the use of a small dose (0.625 mg) of droperidol. In combination with dexamethason (8 mg) droperidol was given as the patient underwent laparoscopic cholecystectomy in order to prevent postoperative nausea and vomiting. The patient presented characteristic signs of ataxia. The signs lasted for 36 hours. We believe that droperidol was the cause. She had previously experienced similar signs after taking metoclopramide.

1.7 nm platinum nanoparticles: synthesis with glucose starch, characterization and catalysis.

Monodisperse platinum nanoparticles (PtNPs) were synthesized by a green recipe. Glucose serves as a reducing agent and starch as a stabilization agent to protect the freshly formed PtNP cores in buffered aqueous solutions. Among the ten buffers studied, 2-(N-morpholino)ethanesulfonic acid (MES), ammonium acetate and phosphate are the best media for PtNP size control and fast chemical preparation. The uniform sizes of the metal cores were determined by transmission electron microscopy (TEM) and found to be 1.8 ± 0.5, 1.7 ± 0.2 and 1.6 ± 0.5 nm in phosphate, MES and ammonium acetate buffer, respectively. The estimated total diameter of the core with a starch coating layer is 5.8-6.0 nm, based on thermogravimetric analysis (TGA). The synthesis reaction is simple, environmentally friendly, highly reproducible, and easy to scale up. The PtNPs were characterized electrochemically and show high catalytic activity for reduction of dioxygen and hydrogen peroxide as well as for oxidation of dihydrogen. The PtNPs can be transferred to carbon support materials with little demand for high specific surface area of carbon. This enables utilization of graphitized carbon blacks to prepare well-dispersed Pt/C catalysts, which exhibit significantly improved durability in the accelerated aging test under fuel cell mimicking conditions.

Cold hyposensitivity after topical application of capsaicin in humans.

Capsaicin activates the transient receptor potential vanilloid 1 receptor (TRPV1) on small sensory afferents, and capsaicin is commonly used to elucidate mechanisms of neuropathic pain. This study was performed to describe changes in cold and cold pain perception after topically applied capsaicin. Fourteen healthy subjects were included. Cold detection and cold pain thresholds and the response to suprathreshold cold stimuli were evaluated before and after topical application of capsaicin (200 microl, 50 mg/ml in 70% ethanol solution, 10.2 cm2) for 30 min. The skin temperature was kept between 34 and 35 degrees C. At the site of capsaicin application (the primary area), we found profound cold hypoesthesia and hypoalgesia, while outside the application site (the secondary area) there were no difference in the changes in cold detection and cold pain thresholds and cold-induced pain compared to the control arm. These results suggest a peripheral mediated decrease in cold sensation following TPRV1 receptor activation.

Repeated prolonged whole-body low-intensity exercise: effects on insulin sensitivity and limb muscle adaptations.

This study investigates the effect of prolonged whole-body low-intensity exercise on insulin sensitivity and the limb muscle adaptive response. Seven male subjects (weight, 90.2 +/- 3.2 kg; age, 35 +/- 3 years) completed a 32-day unsupported crossing of the Greenland icecap on cross-country skies pulling sleighs. The subjects were studied before and 3 to 4 days after the crossing of the icecap. Subjects came in overnight fasted, and an intravenous glucose tolerance test (IVGTT) was done. A biopsy was obtained from the vastus lateralis and deltoid muscle. On a separate day, a progressive test was performed to establish maximal oxygen uptake. During the crossing, subjects skied for 342 +/- 41 min/d. Peak oxygen uptake (4.6 +/- 0.2 L/min) was decreased (P < .05) by 7% after the crossing and body mass decreased (P < .05) by 7.1 +/- 0.2 kg, of which 4.4 +/- 0.5 kg was fat mass and 2.7 +/- 0.2 kg lean body mass. Glycosylated hemoglobin (5.6% +/- 0.01%) was not affected by the crossing. The IVGTT data revealed that insulin sensitivity (7.3 +/- 0.6 mU x L-1 x min-1) and glucose effectiveness (0.024 +/- 0.002 min-1) were not changed after the crossing. Similarly, the IVGTT data, when expressed per kilogram of lean body mass or body mass, were not affected by the crossing. Citrate synthase activity was higher (P < .05) in the leg (29 +/- 1 micromol x g-1 x min-1) than in the arm muscle (16 +/- 2 micromol x g-1 x min-1) and was unchanged after the crossing. Muscle GLUT4 protein concentration was higher (P < .05) in the leg (104 +/- 10 arbitrary units) than in the arm (54 +/- 9 arbitrary units) and was not changed in the leg, but was increased (P < .05) by 70% to 91 +/- 9 arbitrary units in the arm after the crossing. In conclusion, the increased glucose transporter expression in arm muscle may compensate for the loss of lean body mass and the decrease in aerobic fitness and thereby contribute to the maintenance of whole-body insulin sensitivity after prolonged low-intensity exercise training.